Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | VCAM1 | P19320 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | RAF1 | P04049 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | GFER | P55789 | 1/20 | 0.65 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11137980 | 0.87 | ALDH1A1 (0.61) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL12138057 | 0.86 | LMNA (0.56) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL27770136 | 0.85 | VCAM1 (0.70) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL10328475 | 0.85 | VCAM1 (0.70) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL5734347 | 0.85 | VCAM1 (0.68) | LMNAVCAM1MAPTALDH1A1HPGD | |
| SCHEMBL1467163 | 0.83 | HTT (0.73) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL30863327 | 0.83 | VCAM1 (0.66) | LMNAVCAM1MAPTALDH1A1HPGD | |
| SCHEMBL1761873 | 0.83 | VCAM1 (0.62) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL260606 | 0.83 | KMT2A (0.64) | LMNAVCAM1MAPTALDH1A1RAF1 | |
| SCHEMBL1028629 | 0.83 | VCAM1 (0.62) | LMNAVCAM1MAPTALDH1A1RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116332779-B | Preparation method of 3, 4-diaminomethyl benzoate | 苏州敬业医药化工有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-116332779-A | Preparation method of 3, 4-diaminomethyl benzoate | 苏州敬业医药化工有限公司 | 2023-06-27 | — | — | CN | claimed |
| EP-3745105-B1 | TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME | HITACHI LTD (JP) | 2025-08-27 | — | — | EP | disclosed |
| CN-116120239-B | Aromatic six-membered cycloimidazole derivative, and preparation method and application thereof | 沈阳药科大学 | 2025-06-24 | — | — | CN | disclosed |
| US-20250197396-A1 | COMPOUNDS FOR INHIBITING INOSITOL HEXAKISPHOSPHATE KINASE (IP6K) AND METHODS OF USE THEREOF | LIEBER INSTITUTE, INC. | 2025-06-19 | — | — | US | disclosed |
| CN-116332779-B | Preparation method of 3, 4-diaminomethyl benzoate | 苏州敬业医药化工有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-116332779-B | Preparation method of 3, 4-diaminomethyl benzoate | 苏州敬业医药化工有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| US-20250163038-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. | 2025-05-22 | — | — | US | disclosed |
| CN-119100992-A | Preparation method of tergolian intermediate and derivative thereof | 帕潘纳(北京)科技有限公司 | 2024-12-10 | — | — | CN | disclosed |
| US-20240400247-A1 | TEMPERATURE INDICATOR MANUFACTURING SYSTEM AND TEMPERATURE INDICATOR MANUFACTURING METHOD | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-0574494-A1 | INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1993-12-22 | — | — | EP | disclosed |
| US-5159114-A | Anticholesterol agents | RHONE-POULENC SANTE (FR) | 1992-10-27 | — | — | US | disclosed |
| WO-1992014732-A1 | INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1992-09-03 | — | — | WO | disclosed |
| EP-0499987-A1 | Platelet activating factor antagonists | ABBOTT LABORATORIES (US) | 1992-08-26 | — | — | EP | disclosed |
| US-5091394-A | BENZOYLGUANIDINES, A PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND MEDICAMENTS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-02-25 | — | — | US | disclosed |
| EP-0424194-A2 | Benzanilide derivatives and their use as anti-atherosclerotic agents | RHONE-POULENC SANTE (FR) | 1991-04-24 | — | — | EP | disclosed |
| CN-1050018-A | Benzoylguanidines, they the preparation method, they are as the application of medicament and the medicament that contains them | HOECHST AG (DE) | 1991-03-20 | — | — | CN | disclosed |
| US-4916149-A | Diuretic and saluretic 4-chloro-3-sulfamoylbenzoic acid hydrazides | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1990-04-10 | — | — | US | disclosed |
| US-4145342-A | NITRO-DIPHENYLAMINO-AZO-PHENYL DYESTUFFS CONTAINING A POLYALKYENEOXY GROUP | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163038-A1 | CBL-B MODULATORS AND USES THEREOF | CBLB, CBL, CBLC | LMNA 1642/4885VCAM1 3051/4885MAPT 4064/4885 |
| US-20250197396-A1 | COMPOUNDS FOR INHIBITING INOSITOL HEXAKISPHOSPHATE KINASE (IP6K) AND METHODS OF USE THEREOF | IP6K1, IP6K2, IP6K3 | LMNA 3930/4885VCAM1 4338/4885MAPT 4318/4885 |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | ALK, ROS1, NOX1 | LMNA 1817/4885VCAM1 3465/4885MAPT 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.